Researchers at Johns Hopkins are examining the potential for psychoactive drugs to yield a psychedelic experience during an experimental drug administration session.
Participation in the study involves:
Completing six experimental drug administration sessions over approximately six weeks on the Johns Hopkins Bayview Medical Campus
Administration of one of the following:
Placebo
Psilocybin
Ketamine
Dextromethorphan (DXM)
Dimethyltryptamine (DMT)
Methylenedioxymethamphetamine (MDMA)
Tetrahydrocannabinol (THC)
Eligibility requirements:
Age 25-55
Are a healthy individual
Prior use of psychoactive drugs
Ability to attend up to 15 in-person appointments over 6-10 weeks
You may receive up to $2380 for completing all study procedures.
Confidentiality will be maintained for all applicants and participants.
Email for contact: psychoactivestudy@jh.edu
Principal Investigator: Frederick S. Barrett, Ph.D.
Protocol: IRB000376501